Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.
Prophylactic use of antimicrobial agents and microbicides has been proven for many infections, including surgical, gastrointestinal, upper respiratory, and meningococcal infections. Antiretroviral therapy for pregnant women prevents mother-to-child transmission of human immunodeficiency virus (HIV), which has become rare in settings where access to therapy is widespread. Postexposure prophylaxis after needlestick injury or significant sexual exposure is recommended on the basis of animal studies and case-control observational studies, although use of these interventions is limited to those who recognize exposure, have access, and have the power to use the interventions. Clinical trials are evaluating whether regular or preexposure use of antiretroviral therapy provides additional protection for persons at high risk of infection who are also offered standard prevention care, including HIV testing, counseling, condoms, and management of sexually transmitted infections. Trials are evaluating topical or oral use. Concerns have arisen with regard to optimal dosing strategies, costs, access, drug resistance, risk behavior, and the role of communities. Future implementation, if warranted, will be guided by the results of clinical trials in progress and engagement of communities exposed to HIV.
Grant
Robert M
RM
Gladstone Institute of Virology and Immunology and University of California, San Francisco, USA. robert.grant@ucsf.edu
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D009784:Occupational Diseases / Q000517:prevention & control; D016273:Occupational Exposure; D011247:Pregnancy
D044966:Anti-Retroviral Agents
J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):519-25
15021317
J Exp Med. 2007 Apr 16;204(4):705-14
17389241
BMJ. 2006 Mar 11;332(7541):605-7
16528088
Lancet. 2007 Feb 24;369(9562):657-66
17321311
Clin Infect Dis. 2005 Oct 1;41(7):1035-40
16142671
Clin Infect Dis. 2006 Oct 1;43(7):904-10
16941375
Clin Infect Dis. 2005 Nov 15;41(10):1507-13
16231265
Surg Infect (Larchmt). 2006;7 Suppl 2:S37-9
16895502
PLoS Med. 2005 Sep;2(9):e234
16008507
Lancet. 1999 Mar 6;353(9155):773-80
10459957
AIDS. 2003 Apr 11;17(6):937-8
12660549
Science. 2005 Sep 30;309(5744):2170-1
16195446
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):266-71
9402073
Lancet. 2008 Jun 21;371(9630):2109-19
18572080
AIDS. 2005 Nov 4;19(16):1865-75
16227795
N Engl J Med. 1994 Nov 3;331(18):1173-80
7935654
J Infect Dis. 2001 Mar 1;183(5):707-14
11181146
MMWR Recomm Rep. 2005 Jan 21;54(RR-2):1-20
15660015
J Gen Intern Med. 2007 Jul;22(7):1003-6
17390095
J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):241-7
18340656
Nat Med. 1996 Oct;2(10):1084-9
8837605
PLoS Clin Trials. 2007 May 25;2(5):e27
17525796
PLoS Med. 2008 Jan 15;5(1):e16
18198941
PLoS One. 2007 Sep 19;2(9):e875
17878928
Lancet. 1999 Mar 6;353(9155):781-5
10459958
PLoS Med. 2008 Feb;5(2):e28
18254653
Science. 1995 Nov 17;270(5239):1197-9
7502044
AIDS. 2004 Mar 26;18(5):787-92
15075514
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006734
19160297
Clin Infect Dis. 2009 Mar 15;48(6):806-15
19193111
J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):77-83
19295337
Lancet. 1999 Sep 4;354(9181):795-802
10485720
Lancet. 1991 Feb 2;337(8736):253-60
1671109
Clin Infect Dis. 2004 Oct 15;39(8):1190-8
15486844
J Infect Dis. 2003 Mar 1;187(5):725-35
12599045
PLoS Med. 2005 Nov;2(11):e298
16231970
J Virol. 2000 Feb;74(4):1767-74
10644348
J Acquir Immune Defic Syndr. 2005 May 1;39(1):90-101
15851919
AIDS. 2001 Oct 19;15(15):1951-7
11600822
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510
17253490
J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):494-9
18176318
BMC Int Health Hum Rights. 2005 Aug 24;5:6
16120208
Lancet. 2002 Apr 6;359(9313):1178-86
11955535
Lancet. 2007 Feb 24;369(9562):643-56
17321310
J Infect Dis. 2001 Aug 15;184(4):429-38
11471100
Lancet. 2003 Oct 11;362(9391):1171-7
14568737
Lancet. 2008 Dec 6;372(9654):1977-87
19059048
Lancet. 1999 Mar 6;353(9155):786-92
10459959